Evidence map›Paper›PMID 31321757›Full record

ReviewJournal of endocrinological investigation2019

Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults.

C Betterle, F Presotto, J Furmaniak

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of endocrinological investigation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Addison's disease in Italy: mortality and survival by etiology.Journal of endocrinological investigation · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Pregnancy Outcomes in Women With Primary Adrenal Insufficiency: Data From a Multicentre Cohort Study.BJOG : an international journal of obstetrics and gynaecology · 2025
    Article
  15. Article
  16. Article
  17. Non-Hypertensive Effects of Aldosterone.International journal of molecular sciences · 2025
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

C BetterleEndocrine Unit, Department of Medicine (DIMED), University of Padova, Via Ospedale Civile 105, 35128, Padua, Italy.
F PresottoEndocrine Unit, Department of Medicine (DIMED), University of Padova, Via Ospedale Civile 105, 35128, Padua, Italy. fabio.presotto@unipd.it.
J FurmaniakFIRS Laboratories, Llanishen, Cardiff, UK.
University of Padua · ITCardiff University · GB

Funding

C.B. participated to Euradrenal Project: Pathophysiology and Natural Course of Autoimmune Adrenal Failure in Europe Grant Agreement No. 2008-201167 of the European Union 7th Framework Program
6 · The paper itself

Abstract

backgroundAddison's disease (AD) is a rare disorder and among adult population in developed countries is most commonly caused by autoimmunity. In contrast, in children genetic causes are responsible for AD in the majority of patients. PURPOSE: This review describes epidemiology, pathogenesis, genetics, natural history, clinical manifestations, immunological markers and diagnostic strategies in patients with AD. Standard care treatments including the management of patients during pregnancy and adrenal crises consistent with the recent consensus statement of the European Consortium and the Endocrine Society Clinical Practice Guideline are described. In addition, emerging therapies designed to improve the quality of life and new strategies to modify the natural history of autoimmune AD are discussed.

conclusionsProgress in optimizing replacement therapy for patients with AD has allowed the patients to lead a normal life. However, continuous education of patients and health care professionals of ever-present danger of adrenal crisis is essential to save lives of patients with AD.

Indexed as

Hormone Replacement TherapyAddison DiseaseAdrenal Cortex HormonesAdultAge FactorsFemaleHumansIncidenceMalePrevalenceQuality of LifeSex FactorsAdrenal Cortex HormonesAddison’s diseaseAutoimmune polyendocrine syndromesNatural history of Addison’s diseasePrimary adrenal insufficiencyTherapy of Addison’s disease

Identifiers

PMID31321757
OpenAlexW2963116957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.